Entering text into the input field will update the search result below

Stifel likes bluebird bio in premarket analyst action

  • Calithera Biosciences (NASDAQ:CALA) initiated with Buy rating and $6 (34% upside) price target at Jefferies.
  • Soliton (NASDAQ:SOLY) initiated with Buy rating and $14 (59% upside) price target at Roth Capital.
  • Bluebird bio (NASDAQ:BLUE) upgraded to Buy with a $70 (50% upside) price target at Stifel.
  • Charles River Labs (NYSE:CRL) upgraded to Overweight with a $152 (17% upside) price target at Morgan Stanley.
  • Hologic (NASDAQ:HOLX) upgraded to Equal Weight with a $40 (18% upside) price target at Morgan Stanley.
  • NextGen Healthcare (NASDAQ:NXGN) upgraded to Equal Weight at Wells Fargo.
  • Atyr Pharma (NASDAQ:LIFE) downgraded to Neutral at H.C. Wainwright. Shares down 1% premarket.
  • ViewRay (NASDAQ:VRAY) downgraded to Underweight with a $2 (21% downside risk) price target at Morgan Stanley.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CALA--
Calithera Biosciences, Inc.
BLUE--
bluebird bio, Inc.
CRL--
Charles River Laboratories International, Inc.
HOLX--
Hologic, Inc.
NXGN--
NextGen Healthcare, Inc.